(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Cancer of Skin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedikian, AY; Del Vecchio, M | 1 |
Akporiaye, ET; Burch, P; Edmonson, J; Forscher, C; Galanis, E; Gonzalez, R; Hersh, EM; Lewis, BD; O'Driscoll, M; Rinehart, JJ; Rubin, J; Selk, L; Sobol, RE; Sondak, VK; Spier, C; Stopeck, AT; Unger, EC | 1 |
Clark, PR; Ferrari, M; Hersh, EM; Parker, SE; Stopeck, AT | 1 |
1 review(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Cancer of Skin
Article | Year |
---|---|
Allovectin-7 therapy in metastatic melanoma.
Topics: Animals; beta 2-Microglobulin; Cancer Vaccines; Clinical Trials as Topic; DNA, Recombinant; Drug Screening Assays, Antitumor; Genetic Vectors; HLA-B7 Antigen; Humans; Immunotherapy, Active; Injections, Intralesional; Lipids; Lung Neoplasms; Macaca fascicularis; Melanoma; Mice; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Skin Neoplasms; Tumor Escape; Vaccines, DNA | 2008 |
1 trial(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Cancer of Skin
Article | Year |
---|---|
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
Topics: Adult; Aged; Carcinoma, Renal Cell; CD8 Antigens; Dose-Response Relationship, Drug; Female; Gene Transfer Techniques; Genetic Therapy; Humans; Immunohistochemistry; Interleukin-2; Kidney Neoplasms; Lipids; Male; Melanoma; Middle Aged; Plasmids; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Sarcoma; Skin Neoplasms | 1999 |
1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Cancer of Skin
Article | Year |
---|---|
Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
Topics: Animals; DNA; Flow Cytometry; Genetic Therapy; Glycerophospholipids; Green Fluorescent Proteins; Humans; Immunotherapy; Interleukin-2; Lipid Metabolism; Lipids; Luminescent Proteins; Melanoma; Mice; Mice, SCID; Mice, Transgenic; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Skin Neoplasms; Transfection; Tumor Cells, Cultured | 2000 |